Cancer Biotherapy and Radiopharmaceuticals
Last updated ISSN 1084-9785
Cancer Biotherapy and Radiopharmaceuticals is published by Mary Ann Liebert, Inc. in medicine. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Cancer Biotherapy and Radiopharmaceuticals is — and show you journals like it.
What it publishes
Recent work in Cancer Biotherapy and Radiopharmaceuticals concentrates on these topics, taken from its published record rather than from its own description:
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Cancer-related molecular mechanisms research
- Immunotherapy and Immune Responses
- Circular RNAs in diseases
- MicroRNA in disease regulation
- Cancer Immunotherapy and Biomarkers
- Neuroendocrine Tumor Research Advances
- Lymphoma Diagnosis and Treatment
Key facts
| Publisher | Mary Ann Liebert, Inc. |
|---|---|
| ISSN | 1084-9785, 1557-8852 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 2,520 |
| Publishing since | 1996 |
| Journal website | www.liebertpub.com/overview/cancer-biotherapy-and-ra |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Cancer Biotherapy and Radiopharmaceuticals
Other established journals in medicine, if this one is not the right home for your paper: